US Stock MarketDetailed Quotes

ALGS Aligos Therapeutics

Watchlist
  • 23.670
  • +2.660+12.66%
Close Feb 14 16:00 ET
  • 23.700
  • +0.030+0.13%
Pre 04:08 ET
84.93MMarket Cap-3.26P/E (TTM)

Aligos Therapeutics Key Stats

Aligos Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 333.330K--
--2024/Q4-- / 433.330K--
Nov 6, 20242024/Q31.269M / 333.330K--
Aug 6, 20242024/Q21.061M / 0.000--
May 7, 20242024/Q1986.000K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 333.330K--
--2024/Q4-- / 433.330K--
Nov 6, 20242024/Q31.269M / 333.330K--
Aug 6, 20242024/Q21.061M / 0.000--
May 7, 20242024/Q1986.000K / 0.000--

Unlock Free Earnings Estimates

Aligos Therapeutics Earnings Reports

Read more

Trending Stocks

Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More